Feb 26 2010
Electro-Optical Sciences, Inc. (the "Company") (NASDAQ: MELA), announced today that it will be doing business under the name "MELA Sciences" to better reflect the Company's focus on early melanoma detection. The Company's shares will continue to be traded on the NASDAQ capital market under the ticker symbol "MELA."
"We are excited to call ourselves MELA Sciences, which better describes our mission to change the face of melanoma," said Joseph V. Gulfo, MD, President and CEO. "We're committed to offering dermatologists a breakthrough technology to aid in detecting melanoma at its earliest, most curable stage. Through the years of extensively testing, training and developing the MelaFind® system, we have amassed and are continuing to add to a significant database of information about melanoma that we hope will contribute to the understanding of this disease and ultimately help physicians make optimal patient management decisions. When MelaFind is approved, we also plan to work with dermatologists and patient groups to develop disease awareness, patient empowerment and melanoma education programs to encourage patients to take a proactive stance against this deadly disease that currently kills one American every hour."
In concert with doing business under the new name, the Company has re-launched its website, which can now be found at http://www.melasciences.com.
An official change to the Company's legal name will require an amendment to its charter and requisite stockholder approval. The Company plans on holding its annual meeting of stockholders in April 2010.
Source: http://www.melasciences.com